Litcius/Paper detail

FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review

Amal Kamal Abdel‐Aziz, Eman M.E. Dokla, Mona Kamal Saadeldin

2023Critical Reviews in Oncology/Hematology20 citationsDOIOpen Access PDF

Topics & Concepts

Myeloid leukemiaMedicineClinical trialFms-Like Tyrosine Kinase 3Drug resistanceBioinformaticsCancer researchMutationInternal medicineBiologyGeneGeneticsAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsProtein Degradation and Inhibitors
FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review | Litcius